BioNTech SE
BNTX
$105.07
-$5.81-5.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 295.99M | 192.37M | 1.27B | 1.37B | 138.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 295.99M | 192.37M | 1.27B | 1.37B | 138.52M |
| Cost of Revenue | 86.71M | 88.19M | 259.56M | 196.68M | 64.36M |
| Gross Profit | 209.28M | 104.18M | 1.01B | 1.17B | 74.16M |
| SG&A Expenses | 155.94M | 126.91M | 140.81M | 165.46M | 197.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -28.83M | -55.56M | 47.01M | 378.41M | 282.32M |
| Total Operating Expenses | 791.61M | 712.65M | 1.10B | 1.35B | 1.17B |
| Operating Income | -495.62M | -520.28M | 168.96M | 22.98M | -1.04B |
| Income Before Tax | -457.04M | -468.71M | 321.07M | 174.47M | -867.31M |
| Income Tax Expenses | -18.27M | -31.15M | 44.45M | -43.32M | 2.15M |
| Earnings from Continuing Operations | -438.76M | -437.57M | 276.62M | 217.79M | -869.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -438.76M | -437.57M | 276.62M | 217.79M | -869.46M |
| EBIT | -495.62M | -520.28M | 168.96M | 22.98M | -1.04B |
| EBITDA | -437.74M | -475.24M | 296.66M | 71.79M | -981.51M |
| EPS Basic | -1.82 | -1.82 | 1.15 | 0.90 | -3.62 |
| Normalized Basic EPS | -1.11 | -1.15 | 0.92 | 0.57 | -2.19 |
| EPS Diluted | -1.82 | -1.82 | 1.15 | 0.89 | -3.62 |
| Normalized Diluted EPS | -1.11 | -1.15 | 0.92 | 0.56 | -2.19 |
| Average Basic Shares Outstanding | 241.63M | 240.35M | 240.28M | 241.59M | 240.42M |
| Average Diluted Shares Outstanding | 241.63M | 240.35M | 240.28M | 244.57M | 240.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |